Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

U.S. Must Do More To Address Maternal Mortality In Developing Countries, Rep. Moore Writes In Opinion Piece
President Obama and first lady Michelle Obama"s visit to Africa this weekend "will send a powerful message to the world about their commitment to ensuring Africa"s continued progress," Rep. Gwen Moore (D-Wis.) writes in an opinion piece in The Hill. She continues that "for Africa to make this long-forestalled progress, a renewed promise must be made to provide highly cost-effective solutions to ensure that women are healthy before, during and after pregnancy."According to Moore, "More than 500,000 women worldwide die from pregnancy each year, and millions more endure life-threatening complications." For example, in Ghana, women"s risk of pregnancy-related death is one in 45, compared with one in 4,800 in the U.S., she writes. "In some of the world"s poorest countries, including Afghanistan, the maternal death risk is as high as one in eight," Moore adds. Access to health care is a significant part of the problem, she writes, noting that "[o]nly 40% of births worldwide take place in a health facility" and that "[s]ix of the seven countries with the highest levels of maternal mortality have less than one doctor per every 10,000 people."Moore continues that she is "encouraged" that the House Appropriations Committee recently approved increased funding for family planning and maternal and child health as part of the fiscal year 2010 Foreign Operations Appropriations bill (HR 3081). "However, more remains to be done by the United States and our partners around the world if we are truly going to fulfill the promise of the Millennium Development Goals by 2015, one of which is to reduce maternal mortality by three-quarters and achieve universal access to reproductive health," she adds. Although there has been progress in fighting HIV/AIDS and working toward other Millennium Development Goals, "[w]e must recognize the appalling lack of progress that has been made in the area of maternal mortality, child mortality and family planning as major barriers to progress on all of the other goals," according to Moore."Pregnancy, childbirth and motherhood should not be a death sentence," Moore writes. She concludes, "Improving impoverished women"s chances of survival before, during and after pregnancy is an issue of rights and social justice. It is also a sound economic and social investment, given the importance of women to the well-being of their children, families and societies" (Moore, The Hill, 7/7).
generic viagra online
Key Health IT Definition Expected Soon
The Office of the National Coordinator for Health Information Technology"s number-two man, Charles Friedman, told industry members that an official definition of the term "meaningful use" of health information technology is "in the works" and they should expect its release "in the not too distant future." "Meaningful use" refers to the criteria the government will use to determine whether to pay providers for adopting the technology, Modern Healthcare reports.
News of the day
Rosiglitazone Does Not Harm Bone Healing If Combined With Metformin In Rats
Taking the diabetes medications metformin and rosiglitazone together reverses the adverse effects on bone of rosiglitazone treatment alone in an experimental model, according to a new study done in rats. The results were presented at The Endocrine Society"s 91st Annual Meeting in Washington, D.C.
Health Insurance

APhA Seeks Nominations For Scientific Awards And Honors

The American Pharmacists Association (APhA), the national professional society of pharmacists, announces that nominations are now being accepted for the APhA scientific awards and honors that will be presented at the APhA Annual Meeting and Exposition in Washington, DC, March 12-15, 2010. Nominations must be received at APhA headquarters by September 15, 2009. APhA"s awards recognition program is American pharmacy"s most comprehensive recognition program. Guidelines for nominations, the nomination form, and complete criteria for each award are available at www.pharmacist.com/awards. Please submit all nomination materials to: APhA Awards and Honors Program- Attention: Meredith Nelson, 2215 Constitution Avenue, NW, Washington, DC 20037-2985, or email to mnelson@aphanet.org. Nominator and support signatures are required on all letters. Please indicate which awards or honors you wish to make a nomination. For additional questions please contact Meredith Nelson at (202) 429-7559. Awards Takeru Higuchi Research Prize: The award, established in 1981 in honor of Dr. Takeru Higuchi, the first president of the APhA Academy of Pharmaceutical Sciences, recognizes the highest accomplishments in pharmaceutical sciences, and is international in scope and stature. Scientists selected to receive the award shall have demonstrated effective and persistent efforts in pioneering a new concept applicable to the pharmaceutical sciences. Recipients must be an APhA member. Research Achievement Award in the Pharmaceutical Sciences: The award, offered annually and rotated every year among the three APhA Academy of Pharmaceutical Research and Science (APhA-APRS) Sections, is intended to recognize and encourage outstanding, meritorious achievement in any of the pharmaceutical sciences. In 2010, the award will recognize contributions in the area of basic pharmaceutical sciences. Nominees do not have to be members of APhA-APRS, but must be an APhA member. APhA Fellow: This honor recognizes APhA members with a minimum of 10 years of exemplary professional experience and achievements in professional practice, who have rendered outstanding service to the profession through activities in APhA and in other organizations. Examples of service to organizations may include having held an elected or appointed office, service on a committee, expert panel or review board, or other relevant activities. The selection of Fellows is done by the respective academies, with APhA-APRS presenting up to 10 Fellow designations each year. Wiederholt Prize: Established in 1996 as the Best Published Paper Award in Social, Economic and Administrative Sciences and renamed in 2002 as the Wiederholt Prize, this award, presented annually, recognizes the best-published paper describing original investigation in the area of economic, social, or administrative sciences related to pharmacy. The paper must have been published in the Journal of the American Pharmacists Association (JAPhA) within the last two calendar years and the primary author must be an APhA member. Ebert Prize: Established in 1873, the Ebert Prize is the oldest pharmacy award in existence in the United States. This award recognizes the author(s) of the best essay or written communication containing original investigation of a medicinal substance published in the Journal of Pharmaceutical Sciences in the past year. The paper selected must have been published during the calendar year preceding the selection. Awardees need not be members of APhA for consideration. Clinical Research Paper Award: The award, established in 2006, is intended to promote and encourage high quality clinical research or practice based research in the clinical sciences by recognizing an original research article in this area, which has been published in the JAPhA within two years prior to the screening deadline. The primary author (first and/or corresponding author) must be a member of APhA. American Pharmacists Association


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009